Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioPortfolio's Approved Drugs Database

Xolair

Omalizumab

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Press Releases About Xolair:

BioPortfolio Logo
Reportlinker Adds Monoclonal Antibody Therapies 2007: Competitive Landscape and Pipeline Insight 5th November, 2009 Reportlinker
NEW YORK, Nov. 5 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Monoclonal Antibody Therapies 2007: Competitive Landscape and Pipeline
Reportlinker Adds Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment 26th October, 2009 Reportlinker
-- A focus on "engineered" antibodies Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment reviews the broad drug development effort that is focused on bringing
Micromet, Inc. Reports Second Quarter 2008 Financial Results 7th August, 2008 Micromet, Inc.
BETHESDA, Md., Aug. 7 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company focusing on the development of novel, proprietary antibodies for the treatment of cancer,
Sunesis Pharmaceuticals Expands Development Leadership Team to Focus on Late-Stage Development of Voreloxin (Formerly SNS-595) 3rd June, 2008 Sunesis Pharmaceuticals, Inc.
SOUTH SAN FRANCISCO, Calif., June 3 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced the expansion of its late-stage development leadership team with the
Merck & Co - Amrad: an uncertain pathway to success 1st July, 2005 Datamonitor
Merck & Co/Amrad: an uncertain pathway to success Amrad and Merck & Co have selected a lead anti-IL-13 monoclonal antibody for development in severe asthma. The antibody holds

Companies working in the area of Xolair from Bioportfolio's Biocorporate database :

BioPortfolio Logo
Company Name

Tanox

In the 1980s, Tanox scientists discovered a novel approach for the treatment of allergic disease by reducing the levels of immunoglobulin E (IgE) in the blood. IgE is one of a class of antibodies that...
www.tanox.com/        View full profile
Thumbshot

This page has been viewed 60 times
Recent Search Terms used to find this page: is xolair used for allergies | xolair expansion | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Xolair across BioPortfolio, or for Xolair Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.